These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 19644813)

  • 1. [Inflammation, oxidative stress and kidney function in arterial hypertension].
    Cerasola G; Guarneri M; Cottone S
    G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients.
    Cottone S; Mulè G; Guarneri M; Palermo A; Lorito MC; Riccobene R; Arsena R; Vaccaro F; Vadalà A; Nardi E; Cusimano P; Cerasola G
    Nephrol Dial Transplant; 2009 Feb; 24(2):497-503. PubMed ID: 18772174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial function, CRP and oxidative stress in chronic kidney disease.
    Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
    J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among renal function loss within the normal to mildly impaired range, arterial stiffness, inflammation, and oxidative stress.
    Yoshida M; Tomiyama H; Yamada J; Koji Y; Shiina K; Nagata M; Yamashina A
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1118-24. PubMed ID: 17913969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease.
    Himmelfarb J
    Cardiol Clin; 2005 Aug; 23(3):319-30. PubMed ID: 16084281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress is progressively enhanced with advancing stages of CKD.
    Dounousi E; Papavasiliou E; Makedou A; Ioannou K; Katopodis KP; Tselepis A; Siamopoulos KC; Tsakiris D
    Am J Kidney Dis; 2006 Nov; 48(5):752-60. PubMed ID: 17059994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
    Stenvinkel P
    J Ren Nutr; 2003 Apr; 13(2):144-8. PubMed ID: 12671839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction and chronic kidney disease: treatment options.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress.
    Fujii H; Nishijima F; Goto S; Sugano M; Yamato H; Kitazawa R; Kitazawa S; Fukagawa M
    Nephrol Dial Transplant; 2009 Jul; 24(7):2089-95. PubMed ID: 19188341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease.
    Moinuddin I; Leehey DJ
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):83-96. PubMed ID: 18155113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?
    Himmelfarb J
    Semin Dial; 2004; 17(6):449-54. PubMed ID: 15660575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation may be a bridge connecting hypertension and atherosclerosis.
    Li JJ; Chen JL
    Med Hypotheses; 2005; 64(5):925-9. PubMed ID: 15780486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study.
    Solbu MD; Jenssen TG; Eriksen BO; Toft I
    Metabolism; 2009 Mar; 58(3):408-15. PubMed ID: 19217459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
    Minami J; Ishimitsu T; Sudo Y; Matsuoka H
    Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between hyperinsulinemia, hypertension and progressive renal disease.
    El-Atat FA; Stas SN; McFarlane SI; Sowers JR
    J Am Soc Nephrol; 2004 Nov; 15(11):2816-27. PubMed ID: 15504934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.